Jasper Ridge Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.21M | Hold |
105,000
| – | – | 0.21% | 37 |
|
|
2025
Q1 | $7.61M | Hold |
105,000
| – | – | 0.24% | 35 |
|
|
2024
Q4 | $7.77M | Hold |
105,000
| – | – | 0.25% | 36 |
|
|
2024
Q3 | $6.93M | Hold |
105,000
| – | – | 0.2% | 42 |
|
|
2024
Q2 | $9.7M | Hold |
105,000
| – | – | 0.31% | 33 |
|
|
2024
Q1 | $10M | Hold |
105,000
| – | – | 0.32% | 38 |
|
|
2023
Q4 | $8.01M | Hold |
105,000
| – | – | 0.32% | 30 |
|
|
2023
Q3 | $7.27M | Hold |
105,000
| – | – | 0.34% | 29 |
|
|
2023
Q2 | $9.9M | Hold |
105,000
| – | – | 0.5% | 27 |
|
|
2023
Q1 | $8.69M | Hold |
105,000
| – | – | 0.41% | 27 |
|
|
2022
Q4 | $7.83M | Hold |
105,000
| – | – | 0.47% | 25 |
|
|
2022
Q3 | $8.68M | Hold |
105,000
| – | – | 0.58% | 26 |
|
|
2022
Q2 | $9.98M | Hold |
105,000
| – | – | 0.6% | 24 |
|
|
2022
Q1 | $12.4M | Hold |
105,000
| – | – | 0.61% | 25 |
|
|
2021
Q4 | $13.6M | Hold |
105,000
| – | – | 0.51% | 27 |
|
|
2021
Q3 | $11.9M | Hold |
105,000
| – | – | 0.53% | 31 |
|
|
2021
Q2 | $10.9M | Hold |
105,000
| – | – | 0.54% | 30 |
|
|
2021
Q1 | $8.78M | Hold |
105,000
| – | – | 0.4% | 28 |
|
|
2020
Q4 | $9.58M | Hold |
105,000
| – | – | 0.42% | 28 |
|
|
2020
Q3 | $8.38M | Buy |
+105,000
| New | +$8.38M | 0.48% | 29 |
|